DTaP-Hib vaccine
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Hib vaccine | Vaccine |
| Clinical data | |
| Trade names | TriHIBit[1] |
| Routes of administration | Intramuscular injection |
| ATC code | |
| Identifiers | |
| CAS Number | |
DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib.[2] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.[3][4]
A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB.[3][5][6] TriHIBit and Tripedia were discontinued in 2011.[7]
See also
[edit]References
[edit]- ^ "Trihibit Side Effects: Common, Severe, Long Term". Drugs.com. 2 December 2024. Retrieved 20 January 2025.
- ^ "Trihibit (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid) Disease Interactions". Drugs.com. Retrieved 15 July 2018.
- ^ a b "Notice to Readers FDA Approval of a Haemophilus b Conjugate Vaccine Combined by Reconstitution with an Acellular Pertussis Vaccine" (PDF). MMWR. Morbidity and Mortality Weekly Report. 45 (45): 993–995. November 1996. PMID 9005308.
- ^ Dhillon S, Keam SJ (2008). "DTaP-IPV/Hib vaccine (Pentacel)". Paediatric Drugs. 10 (6): 405–16. doi:10.2165/0148581-200810060-00008. PMID 18998751.
- ^ "Tripedia package insert" (PDF). US Food and Drug Administration. Archived from the original (PDF) on 12 January 2017. Retrieved 15 July 2018.
- ^ "ActHIB package insert" (PDF). U.S. Food and Drug Administration (FDA). Retrieved 15 July 2018.
- ^ "Selected Discontinued U.S. Vaccines" (PDF). Centers for Disease Control and Prevention. Retrieved 15 July 2018.[dead link]
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |